ScoreWhy is Astrana Health, Inc. ?
1
High Management Efficiency with a high ROE of 19.00%
2
The company is Net-Debt Free
3
Healthy long term growth as Net Sales has grown by an annual rate of 35.87%
4
With a growth in Net Profit of 36.73%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- CASH AND EQV(HY) Highest at USD 880.53 MM
- DEBTORS TURNOVER RATIO(HY) Highest at 8.96 times
- NET SALES(Q) Highest at USD 972.52 MM
5
With ROE of 3.03%, it has a very expensive valuation with a 1.75 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 24.24%, its profits have fallen by -52.4%
6
High Institutional Holdings at 67.74%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 7.64% over the previous quarter.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Astrana Health, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Astrana Health, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Astrana Health, Inc.
24.24%
-0.19
68.46%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.87%
EBIT Growth (5y)
-0.49%
EBIT to Interest (avg)
9.93
Debt to EBITDA (avg)
0.40
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.65
Tax Ratio
40.84%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
60.10%
ROCE (avg)
20.10%
ROE (avg)
19.00%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
1.75
EV to EBIT
25.20
EV to EBITDA
15.92
EV to Capital Employed
1.42
EV to Sales
0.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.62%
ROE (Latest)
3.02%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
CASH AND EQV(HY)
Highest at USD 880.53 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 8.96 times
NET SALES(Q)
Highest at USD 972.52 MM
OPERATING PROFIT(Q)
Highest at USD 49.87 MM
OPERATING PROFIT MARGIN(Q)
Highest at 5.13 %
PRE-TAX PROFIT(Q)
Highest at USD 22.48 MM
NET PROFIT(Q)
Highest at USD 16.53 MM
EPS(Q)
Highest at USD 0.4
-9What is not working for the Company
INTEREST(HY)
At USD 32.1 MM has Grown at 118.5%
RAW MATERIAL COST(Y)
Grown by 17.77% (YoY
Here's what is working for Astrana Health, Inc.
Pre-Tax Profit
At USD 22.48 MM has Grown at 84.81%
over average net sales of the previous four periods of USD 12.16 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 16.53 MM has Grown at 128.15%
over average net sales of the previous four periods of USD 7.25 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 972.52 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 49.87 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 5.13 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 22.48 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 16.53 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.4
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 880.53 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 8.96 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Astrana Health, Inc.
Interest
At USD 32.1 MM has Grown at 118.5%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Raw Material Cost
Grown by 17.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
